retatrutide and bac water 10ml | Peptide Reconstitution retatrutide mixing with bac water

Retatrutide is a triple agonist of GIP, GLP-1, and glucagon receptors, not a third-generation GLP-1

Patients taking orforglipron experienced an average weight loss of approximately 6.14 kg compared to those on placebo

It is widely examined for its impact on body composition, particularly in enhancing lean muscle while helping reduce excess abdominal fat

The 5mg dose produced 15.0% average weight loss

Many patients successfully maintain weight loss on 40-60% of their peak dose, significantly lowering annual expenditure

We will continue to monitor TRIUMPH-1 and the broader retatrutide development program as data becomes available